Sinotherapeutics is a Pharmaceutical company, Manufacturer/Innovator, Contract Service, CMO/CDMO, Contract Research Organisation (CRO) company operating in the pharmaceutical industry.
Sinotherapeutics was founded in 2012, and now listed on China STAR Market. We provide One-stop Formulation Development CRO and CDMO services for new drug candidates with established advanced formulation R&D and manufacturing platforms. The headquarter and R&D center is located in Shanghai with well setup for formulation and analytical labs. Our manufacturing site is located in Jiangsu and has been inspected multiple times by US FDA and Chinese NMPA. We have an excellent track record in providing services from pre-clinical to commercialization stage.
Company type
Pharmaceutical company, Manufacturer/Innovator, Contract Service, CMO/CDMO, Contract Research Organisation (CRO)
Products and services
Biopharmaceuticals, Custom Manufacturing
Markets
North America (USA, Canada), Middle East Region (e.g. UAE), East Asia (e.g. China, Japan, Korea), Europe – EU countries, South East Asia (e.g. Thailand, Philippines, Singapore)
Address
Sinotherapeutics, 99 Haike Road, Building 3, 1st Floor, Pudong New District, Shanghai, China,
